[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"vibration-therapy\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:vibration-therapy":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,5,0,[8,49,77,107,132],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":20,"enrollmentInfo":21,"targetDuration":4,"studyType":24,"phases":25,"briefSummary":27,"conditions":28,"keywords":32,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":48},"100594563","muscle-vibration-as-a-countermeasure-against-hypoactivity-induced-100594563",false,"NCT07021079","Muscle Vibration as a Countermeasure Against Hypoactivity-induced","Effects of Focal Muscle Vibration as a Countermeasure Against Hypoactivity-induced Neuromuscular Deconditioning","NEUROVIB-ULLS","Inclusion Criteria:\n\n* Men and women.\n* Aged 18 to 45 years.\n* Body Mass Index (BMI) between 18,5 and 24,9 kg\u002Fm².\n* Engaging in at least 1.5 hours per week of physical activity (e.g., brisk walking, running, swimming, cycling).\n* Provided informed consent after receiving detailed information about the study.\n* Affiliated with or beneficiaries of a social security system\n\nExclusion Criteria:\n\n* Chronic cardiovascular, neuromuscular, bone, metabolic, and\u002For inflammatory disorders.\n* Personal history and\u002For risk factors for thrombosis.\n* Use of antidepressant medications.\n* Use of neuroactive substances likely to alter corticospinal excitability (e.g., hypnotics, antiepileptics, psychotropics, muscle relaxants) during the study.\n* Recent bone or ligament trauma within the past 12 months.\n* Inability to perform the physical efforts required for the study.\n* Recent participation in a sporting competition or intense, unusual physical activity within the past month.\n* Corticosteroid treatment within the past 3 months.\n* Any skin lesions at the planned vibrator application site.\n* Simultaneous participation in another interventional medical study.\n* Pregnant or breastfeeding women.\n* Individuals unable to understand the purpose and conditions of the study or unable to provide informed consent.\n* Individuals deprived of liberty or under guardianship",true,"ALL","19 Years","45 Years",{"count":22,"type":23},42,"ESTIMATED","INTERVENTIONAL",[26],"NA","Muscle deconditioning, characterized by a loss of muscle mass and strength, is a frequent consequence of prolonged lower limb unloading. Beyond muscle mass loss, reduced neural drive contributes significantly to strength decline, highlighting the need for interventions targeting neuromuscular function during immobilization. Focal muscle vibration (FMV) has shown promise in modulating neuromuscular excitability by activating muscle spindle afferents and inducing cortical adaptations. Chronic use of FMV has been associated with significant strength gains and improved neural command. This makes FMV an effective rehabilitation tool. Its simplicity and non-invasiveness further make it a practical countermeasure.",[29,30,31],"Vibration Therapy","Healthy Volunteer Study","Hypoactivity",[33,34,35],"hypoactivity","neuromuscular deconditionning","Vibration","RECRUITING","2026-05-22",{"date":39,"type":40},"2026-05-26","ACTUAL",{"date":42,"type":40},"2025-06-16",{"date":44,"type":23},"2027-08-31",{"name":46,"class":47},"Centre Hospitalier Universitaire de Saint Etienne","OTHER",1,{"id":50,"slug":51,"hasResults":11,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":4,"eligibilityCriteria":55,"healthyVolunteers":11,"sex":18,"minAge":56,"maxAge":57,"enrollmentInfo":58,"targetDuration":4,"studyType":60,"phases":4,"briefSummary":61,"conditions":62,"keywords":65,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":48},"100628202","vibandz-feasibility-study-100628202","NCT07458568","ViBandz Feasibility Study","ViBandz Feasibility Study in the Neurological Pediatric Population","Inclusion Criteria (Children):\n\n* Children of ages 6 months to 17 years old\n* Neurologic conditions resulting in abnormal movement of at least one extremity\n* Appointment scheduled in CM PT\u002FOT clinic that would include targeted focal vibration as a standard of care\n\nExclusion Criteria (Children):\n\n* Wards of the state\n\nInclusion Criteria (Parent\u002FLAR):\n\n* Parent or Legally Authorized Representative of a child with inclusion criteria above\n* English-speaking\n\nExclusion Criteria (Parent\u002FLAR):\n\n* Non-English speaking","6 Months","17 Years",{"count":59,"type":23},30,"OBSERVATIONAL","This is a single site, mixed methods, feasibility study of the ViBandz device at a Midwest pediatric tertiary care hospital in a physical and occupational therapy clinic.",[63,64,29],"Pediatrics","Neurologic Dysfunction",[66,67],"pediatrics","vibration therapy","2026-04-22",{"date":70,"type":40},"2026-04-27",{"date":72,"type":40},"2026-04-07",{"date":74,"type":23},"2026-12-31",{"name":76,"class":47},"Children's Mercy Hospital Kansas City",{"id":78,"slug":79,"hasResults":11,"nctId":80,"briefTitle":81,"officialTitle":82,"acronym":83,"eligibilityCriteria":84,"healthyVolunteers":11,"sex":18,"minAge":85,"maxAge":86,"enrollmentInfo":87,"targetDuration":4,"studyType":24,"phases":89,"briefSummary":90,"conditions":91,"keywords":95,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":98,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":48},"100633620","the-potential-of-robotic-assisted-gait-training-in-a-rehabilitation-setting-100633620","NCT07529054","The Potential of Robotic-Assisted Gait Training in a Rehabilitation Setting","The Potential of Robotic-Assisted Gait Training in a Rehabilitation Settin","RAGT_RGB","Inclusion Criteria:\n\n* Diagnosis of stroke (ischemic or hemorrhagic) ≥ 3 months\n* Age ≥ 18a and ≤ 80a\n* 6MWT ≤ 200m\n* Barthel Index ≤ 95\n* Mini Mental State Exam (MMSE) ≥ 24\n* FAC: ≤ 4\n* BBS): ≤49\n* Modified Ashworth Scale (MAS): 0-3 for the lower extremity\n\nExclusion Criteria:\n\n* The presence of any comorbidity or disability other than stroke that would preclude gait training\n* Any uncontrolled health condition for which exercise is contraindicated","18 Years","80 Years",{"count":88,"type":23},40,[26],"Robotic-assisted gait training (RAGT) devices, such as the Lokomat®, are commonly used to support gait rehabilitation by enabling repetitive, task-specific walking movements. The functional proprioceptive stimulation (FPS) device Vibramoov® represents a novel technology designed to stimulate proprioceptors at the muscle-tendon junction through targeted vibratory stimuli, thereby activating sensorimotor centers in the brain and potentially facilitating movement execution.\n\nThe aim of this randomized controlled trial is to investigate whether Lokomat® training combined with Vibramoov® leads to greater improvements in qualitative and quantitative gait parameters in stroke patients compared with Lokomat® training alone. The study will be conducted at the Gröbming Rehabilitation Center and will include patients undergoing a four-week neurological inpatient rehabilitation program. Participants will be randomly assigned to an intervention group (Lokomat® + Vibramoov®) or a control group (Lokomat® only), with 20 patients per group.\n\nPrimary outcomes include the 6-Minute Walk Test (6MWT) and spatiotemporal gait parameters. Additional assessments include functional scores, patient-reported outcome measures, and blood biomarkers. Statistical analyses will be performed depending on data distribution. A follow-up assessment evaluating EQ-5D and PHQ-4 will be conducted six months after completion of the rehabilitation program.",[92,93,29,94],"Stroke","Robotic Assisted Gait Training","Gait Biomechanics",[93,96,97],"Functional Proprioceptive Stimulation","Gait Parameter",{"date":99,"type":40},"2026-04-14",{"date":101,"type":40},"2026-01-05",{"date":103,"type":23},"2027-12",{"name":105,"class":106},"Ludwig Boltzmann Institute for Arthritis and Rehabilitation","NETWORK",{"id":108,"slug":109,"hasResults":11,"nctId":110,"briefTitle":111,"officialTitle":112,"acronym":4,"eligibilityCriteria":113,"healthyVolunteers":11,"sex":18,"minAge":114,"maxAge":115,"enrollmentInfo":116,"targetDuration":4,"studyType":24,"phases":118,"briefSummary":119,"conditions":120,"keywords":4,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":123,"lastUpdatePostDateStruct":124,"startDateStruct":126,"completionDateStruct":128,"leadSponsor":130,"locationsCount":48},"100547865","the-effects-of-different-vibration-exercises-on-copd-patients-100547865","NCT06413524","The Effects of Different Vibration Exercises on COPD Patients","The Effects of Different Vibration Exercises on the Strength of Lower Extremity Muscles, Exercise Endurance, and Quality of Life Among COPD Patients","Inclusion Criteria:\n\n1. Age ≥ 40.\n2. Diagnosis of chronic obstructive pulmonary disease (COPD) based on the criteria established by the Global Initiative for Chronic Obstructive Lung Disease (GOLD).\n3. Disease Severity: FEV1 \\< 50% or COPD patients who have used systemic corticosteroids due to an acute exacerbation of COPD within the past year and are currently in a stable condition.\n4. Willingness to participate in vibration exercise intervention and ability to comply with the study activities, including signing the informed consent form.\n5. Clear consciousness, normal cognitive function, and ability to communicate in Mandarin or Taiwanese for understanding experimental procedures and relevant instructions.\n\nExclusion Criteria:\n\n1. Engages in regular physical activity, exercising at least 3 times a week for over 30 minutes, with a Borg Scale rating of 3 for breathlessness after exercise.\n2. The interval since the last pulmonary rehabilitation is less than three months.\n3. Contraindications to vibration therapy: pregnancy, cardiovascular diseases (with a pacemaker or stent), intervertebral disc diseases, tendinitis, arthritis, hernia, presence of tumors, orthopedic or trauma-related conditions, epilepsy, history of deep vein thrombosis, patients with internal implants.\n4. Inability to undergo training or walk due to physical factors, such as being bedridden for an extended period, relying on a ventilator for an extended period, prone to dizziness, central nervous system disorders, etc.\n5. Underwent lower limb-related surgery within the past year or is in the recovery period post-surgery.\n6. Currently diagnosed with cancer or undergoing cancer treatment.\n7. Participation in other research studies.","40 Years","99 Years",{"count":117,"type":23},18,[26],"Pulmonary rehabilitation is effective in improving exercise tolerance, dyspnea, and fatigue in patients with COPD, and exercise training is an important component of pulmonary rehabilitation. Vibration training can be used as a supplement or alternative to traditional exercise and is a short, safe rehabilitation training.\n\nCOPD patients will be recruited and randomly assigned to the control group, whole-body vibration training group, or local vibration training group. The study aims to confirm the rehabilitative benefits of enhancing lower limb muscle strength, exercise endurance, and the quality of life related to COPD in patients.",[121,122,29],"COPD","COPD Chronic Obstructive Pulmonary Disease","2025-01-14",{"date":125,"type":40},"2025-01-16",{"date":127,"type":40},"2024-08-08",{"date":129,"type":23},"2025-06-13",{"name":131,"class":47},"Taipei Medical University",{"id":133,"slug":134,"hasResults":11,"nctId":135,"briefTitle":136,"officialTitle":137,"acronym":4,"eligibilityCriteria":138,"healthyVolunteers":11,"sex":18,"minAge":85,"maxAge":139,"enrollmentInfo":140,"targetDuration":4,"studyType":24,"phases":142,"briefSummary":143,"conditions":144,"keywords":4,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":147,"lastUpdatePostDateStruct":148,"startDateStruct":150,"completionDateStruct":152,"leadSponsor":154,"locationsCount":48},"100567936","effect-of-vibrotactile-stimulation-in-lateral-epicondylitis-100567936","NCT06674668","Effect of Vibrotactile Stimulation in Lateral Epicondylitis","Immediate Effect of Wearable Vibrotactile Stimulation on Pain and Sense in Patients with Lateral Epicondylitis","Inclusion Criteria:\n\n* Being between 18-65 years of age\n* Patients diagnosed with lateral epicondylitis\n\nExclusion Criteria:\n\n* Having had elbow surgery\n* Having a history of congenital or acquired orthopedic, neurological, or rheumatological conditions affecting the upper limb\n* Having received any conservative treatment for the diagnosis of lateral epicondylitis","65 Years",{"count":141,"type":23},33,[26],"It is aimed to investigate the immediate effect of vibrotactile stimulation on pain, sense and functionality in patients with lateral epicondylitis.",[145,29,146],"Lateral Epicondylitis","Physiotherapy","2024-11-04",{"date":149,"type":40},"2024-11-05",{"date":151,"type":40},"2023-06-14",{"date":153,"type":23},"2024-12",{"name":155,"class":47},"Medipol University"]